We are live on
!
Find out more
BIA
Biondo Investment Advisors Portfolio holdings
AUM
$780M
1-Year Est. Return
21.03%
This Fund
S&P 500
This Quarter
Est. Return
+7.11%
1 Year Est. Return
+21.03%
3 Year Est. Return
+89.14%
5 Year Est. Return
+116.93%
10 Year Est. Return
+716.37%
AUM
$676M
AUM Growth
+$28.8M
(+4.5%)
Cap. Flow
+$1.28M
Cap. Flow
% of AUM
0.19%
Top 10 Holdings %
Top 10 Hldgs %
48.49%
Holding
93
New
3
Increased
59
Reduced
15
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vertex Pharmaceuticals
VRTX
|
+$10.3M |
| 2 |
Transmedics
TMDX
|
+$6.41M |
| 3 |
ASML
ASML
|
+$1.07M |
| 4 |
Chevron
CVX
|
+$322K |
| 5 |
Procter & Gamble
PG
|
+$307K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
|
+$12.7M |
| 2 |
EXAS
Exact Sciences
EXAS
|
+$7.95M |
| 3 |
Apple
AAPL
|
+$1.01M |
| 4 |
NVIDIA
NVDA
|
+$836K |
| 5 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$619K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.83% |
| 2 | Healthcare | 25.79% |
| 3 | Consumer Discretionary | 8.29% |
| 4 | Financials | 7.68% |
| 5 | Communication Services | 6.14% |
Similar funds
LA
UBV
SG
RTM
TCMX
QCMNJ
TIS
MO
Biondo Investment Advisors's Q2 2024 Portfolio in Review
As of Q2 2024, Biondo Investment Advisors held 93 positions worth $676M, up 4.5% from $647M the previous quarter. Its ten largest holdings account for 48% of the portfolio.
Biondo Investment Advisors's Q2 2024 filing shows 3 new, 59 increased, 15 reduced and 4 closed positions. Its largest new stake was Transmedics: 53,405 shares worth $8.04M. The largest sale was Shockwave Medical, Inc. Common Stock, an estimated $12.7M.
By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 28% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Biondo Investment Advisors's largest Q2 2024 buy was Transmedics: 53,405 shares worth $8.04M.
- Biondo Investment Advisors added most to Vertex Pharmaceuticals in Q2 2024, an estimated $10.3M increase.
- Biondo Investment Advisors's biggest Q2 2024 reduction was Apple, cutting an estimated $1.01M.
- Biondo Investment Advisors fully exited Shockwave Medical, Inc. Common Stock in Q2 2024, selling an estimated $12.7M.
- Biondo Investment Advisors's ten largest holdings make up 48% of its $676M portfolio in Q2 2024.
- Biondo Investment Advisors opened 3 new positions and closed 4 in Q2 2024.
- Biondo Investment Advisors's portfolio value rose 4.5% quarter-over-quarter to $676M.
Based on Biondo Investment Advisors's 13F filing for Q2 2024, filed 13 Aug 2024.